← Leaderboards
Carol A Bova
Yale University
$653,792
Attributed
$653,792
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $244.3K · FY2010–11$250K$187.5K$125K$62.5K$0
'10
'11
Funding mix
By agency
NIH$653,792 · 3
By mechanism
R21$449,700 · 1
R15$159,000 · 1
F32$45,092 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Hedy Kober$11,564,837
- Rajita Sinha$53,551,446
- Stephanie S O'Malley$41,813,757
- Scott W Woods$46,801,415
- Murat Gunel$29,485,998
Others in their field
Top investigators on “Interview”
- David R. Weir · University Of Michigan At Ann Arbor$402,025,081
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$92,110,019
- Linda J Waite · University Of Chicago$88,691,160
- Robert J Willis · University Of Michigan At Ann Arbor$71,166,480
- Arie Kapteyn · Rand Corporation$66,087,233
- Narayan Sastry · University Of Michigan At Ann Arbor$62,231,924
Research focus
InterviewHepatitis C VirusHepatitis CAdultAppointmentBaseEducational WorkshopBenefits And RisksAnti-Retroviral AgentsDecision MakingChronic DiseaseChronic Hepatitis CCirrhosisClinicClinical ResearchClinical CareClinical TrialsCognitiveCommunicationComorbidityComplexConflict (Psychology)ConsciousAffect
Grant awards (4)
Feasibility of a HCV Decision-Making Intervention among HIV-Infected Adults$244,283
R21 · FY2011 · NR · contact PI
Feasibility of a HCV Decision-Making Intervention among HIV-Infected Adults$205,417
R21 · FY2010 · NR · contact PI
HIV-Infected Patients'Experiences with HCV Treatment$159,000
R15 · FY2003 · NR
DEPRESSION, DUAL DIAGNOSIS AND ANTIRETROVIRAL ADHERENCE$45,092
F32 · FY2001 · NR